Jiajun CHEN

Jiajun Chen is an experienced professional in market access with a focus on Health Economics and Outcomes Research (HEOR) and real-world survey methodologies. Currently serving as the HE&HTA Manager at 罗氏制药, Jiajun manages HTA strategies for hematology and immunology. Jiajun previously held positions at AbbVie, where responsibilities included developing access strategies for pipeline oncology products, and at Pierre Fabre Group, where they led HE projects and contributed to successful NRDL negotiations. Jiajun holds a Master of Science in Health Economics and Decision Modelling from The University of Sheffield and a Bachelor's degree in Marketing from China Pharmaceutical University.